Oesterle Stephen N.
SEC-identified person · CIK 1174532 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Baxter International INC NYSE: BAX | Director | filed 2017–2025 |
| Paragon 28, Inc. FNA | Director | filed 2021–2025 |
| Sigilon Therapeutics, Inc. SGTX | Director | filed 2020–2023 |
| Montes Archimedes Acquisition Corp MAAC | Director | filed 2020–2021 |
| Reva Medical, Inc. RVA:AX | Director | filed 2018–2018 |
| Heartware LTD HTWR | Director | filed 2016–2016 |
| Medtronic INC mdt | SrVP Medicine & Technology | filed 2006–2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.